IL-35 suppresses lipopolysaccharide-induced airway eosinophilia in EBI3-deficient mice

Journal of Immunology

Volumn 198, Issue 1, 2017, Pages 119-127

  Kanai, Kyosuke ^a   Park, Ah Mee ^a   Yoshida, Hiroki ^b   Tsunoda, Ikuo ^a   Yoshie, Osamu ^a,c  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c Sendai Taihaku Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; EOTAXIN 2; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 27 RECEPTOR ALPHA; INTERLEUKIN 35; LIPOPOLYSACCHARIDE; PROTEIN P28; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; CYTOKINE RECEPTOR; EBI3 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, MOUSE; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHUS EPITHELIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; EOSINOPHILIA; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RESPIRATORY TRACT INFLAMMATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DEFICIENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LOEFFLER PNEUMONIA; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CHEMOKINE CCL11; CHEMOKINE CCL24; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MINOR HISTOCOMPATIBILITY ANTIGENS; POLYMERASE CHAIN REACTION; PULMONARY EOSINOPHILIA; RECEPTORS, CYTOKINE;

EID: 85006971400     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600506     Document Type: Article

References (39)

1. Vignali, D. A., and V. K. Kuchroo. 2012. IL-12 family cytokines: immunological playmakers. Nat. Immunol. 13: 722-728.
2. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
3. Olson, B. M., J. A. Sullivan, and W. J. Burlingham. 2013. Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance. Front. Immunol. 4: 315.
4. Aggarwal, S., N. Ghilardi, M. H. Xie, F. J. de Sauvage, and A. L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278: 1910-1914.
5. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
6. Langrish, C. L., B. S. McKenzie, N. J. Wilson, R. de Waal Malefyt, R. A. Kastelein, and D. J. Cua. 2004. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202: 96-105.
7. Perona-Wright, G., J. E. Kohlmeier, E. Bassity, T. C. Freitas, K. Mohrs, T. Cookenham, H. Situ, E. J. Pearce, D. L. Woodland, and M. Mohrs. 2012. Persistent loss of IL-27 responsiveness in CD8+ memory T cells abrogates IL-10 expression in a recall response. Proc. Natl. Acad. Sci. USA 109: 18535-18540.
8. Yoshida, H., and C. A. Hunter. 2015. The immunobiology of interleukin-27. Annu. Rev. Immunol. 33: 417-443.
9. Aparicio-Siegmund, S., and C. Garbers. 2015. The biology of interleukin-27 reveals unique pro- and anti-inflammatory functions in immunity. Cytokine Growth Factor Rev. 26: 579-586.
10. Collison, L. W., V. Chaturvedi, A. L. Henderson, P. R. Giacomin, C. Guy, J. Bankoti, D. Finkelstein, K. Forbes, C. J. Workman, S. A. Brown, et al. 2010. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol. 11: 1093-1101.
11. Egwuagu, C. E., C. R. Yu, L. Sun, and R. Wang. 2015. Interleukin 35: critical regulator of immunity and lymphocyte-mediated diseases. Cytokine Growth Factor Rev. 26: 587-593.
12. Rosser, E. C., and C. Mauri. 2015. Regulatory B cells: origin, phenotype, and function. Immunity 42: 607-612.
13. Dang, V. D., E. Hilgenberg, S. Ries, P. Shen, and S. Fillatreau. 2014. From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets. Curr. Opin. Immunol. 28: 77-83.
14. Shen, P., and S. Fillatreau. 2015. Antibody-independent functions of B cells: a focus on cytokines. Nat. Rev. Immunol. 15: 441-451.
15. Li, X., J. Mai, A. Virtue, Y. Yin, R. Gong, X. Sha, S. Gutchigian, A. Frisch, I. Hodge, X. Jiang, et al. 2012. IL-35 is a novel responsive anti-inflammatory cytokine - a new system of categorizing anti-inflammatory cytokines. PLoS One 7: e33628.
16. Collison, L. W., G. M. Delgoffe, C. S. Guy, K. M. Vignali, V. Chaturvedi, D. Fairweather, A. R. Satoskar, K. C. Garcia, C. A. Hunter, C. G. Drake, et al. 2012. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13: 290-299.
17. Collison, L. W., C. J. Workman, T. T. Kuo, K. Boyd, Y. Wang, K. M. Vignali, R. Cross, D. Sehy, R. S. Blumberg, and D. A. Vignali. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
18. Dokmeci, E., L. Xu, E. Robinson, K. Golubets, K. Bottomly, and C. A. Herrick. 2011. EBI3 deficiency leads to diminished T helper type 1 and increased T helper type 2 mediated airway inflammation. Immunology 132: 559-566.
19. Igawa, T., H. Nakashima, A. Sadanaga, K. Masutani, K. Miyake, S. Shimizu, A. Takeda, S. Hamano, and H. Yoshida. 2009. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod. Rheumatol. 19: 33-41.
20. Yoshida, H., S. Hamano, G. Senaldi, T. Covey, R. Faggioni, S. Mu, M. Xia, A. C. Wakeham, H. Nishina, J. Potter, et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15: 569-578.
21. -ΔΔCTmethod. Methods 25: 402-408.
22. Reddel, R. R., Y. Ke, B. I. Gerwin, M. G. McMenamin, J. F. Lechner, R. T. Su, D. E. Brash, J. B. Park, J. S. Rhim, and C. C. Harris. 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48: 1904-1909.
23. Foster, K. A., C. G. Oster, M. M. Mayer, M. L. Avery, and K. L. Audus. 1998. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp. Cell Res. 243: 359-366.
24. Zlotnik, A., and O. Yoshie. 2012. The chemokine superfamily revisited. Immunity 36: 705-716.
25. Lilly, C. M., H. Nakamura, H. Kesselman, C. Nagler-Anderson, K. Asano, E. A. Garcia-Zepeda, M. E. Rothenberg, J. M. Drazen, and A. D. Luster. 1997. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J. Clin. Invest. 99: 1767-1773.
26. Jedrzkiewicz, S., H. Nakamura, E. S. Silverman, A. D. Luster, N. Mansharamani, K. H. In, G. Tamura, and C. M. Lilly. 2000. IL-1β induces eotaxin gene transcription in A549 airway epithelial cells through NF-kappaB. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L1058-L1065.
27. Faffe, D. S., L. Flynt, M. Mellema, P. E. Moore, E. S. Silverman, V. Subramaniam, M. R. Jones, J. P. Mizgerd, T. Whitehead, A. Imrich, et al. 2005. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13. J. Allergy Clin. Immunol. 115: 514-520.
28. Saleh, A., L. Shan, A. J. Halayko, S. Kung, and A. S. Gounni. 2009. Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells. J. Immunol. 182: 3357-3365.
29. Babon, J. J., L. N. Varghese, and N. A. Nicola. 2014. Inhibition of IL-6 family cytokines by SOCS3. Semin. Immunol. 26: 13-19.
30. Tong, H., Y. Miyazaki, M. Yamazaki, H. Hara, H. Waldmann, S. Hori, and H. Yoshida. 2010. Exacerbation of delayed-type hypersensitivity responses in EBV-induced gene-3 (EBI-3)-deficient mice. Immunol. Lett. 128: 108-115.
31. Whitehead, G. S., R. H. Wilson, K. Nakano, L. H. Burch, H. Nakano, and D. N. Cook. 2012. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 129: 207-215.e1-5.
32. Tirotta, E., P. Duncker, J. Oak, S. Klaus, M. R. Tsukamoto, L. Gov, and T. E. Lane. 2013. Epstein-Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis. J. Neuroimmunol. 254: 110-116.
33. Wirtz, S., U. Billmeier, T. Mchedlidze, R. S. Blumberg, and M. F. Neurath. 2011. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141: 1875-1886.
34. Dong, J., C. K. Wong, Z. Cai, D. Jiao, M. Chu, and C. W. Lam. 2015. Amelioration of allergic airway inflammation in mice by regulatory IL-35 through dampening inflammatory dendritic cells. Allergy 70: 921-932.
35. Hogan, S. P., and M. E. Rothenberg. 2006. Eosinophil function in eosinophil-associated gastrointestinal disorders. Curr. Allergy Asthma Rep. 6: 65-71.
36. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
37. Giovannini-Chami, L., S. Blanc, A. Hadchouel, A. Baruchel, R. Boukari, J. C. Dubus, M. Fayon, M. Le Bourgeois, N. Nathan, M. Albertini, et al. 2016. Eosinophilic pneumonias in children: a review of the epidemiology, diagnosis, and treatment. Pediatr. Pulmonol. 51: 203-216.
38. Eng, S. S., and M. L. DeFelice. 2016. The role and immunobiology of eosinophils in the respiratory system: a comprehensive review. Clin. Rev. Allergy Immunol. 50: 140-158.
39. George, L., and C. E. Brightling. 2016. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease. Ther. Adv. Chronic Dis. 7: 34-51.